Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?

SIMPLE SUMMARY: Renal cell carcinoma (RCC) is the most common form of kidney cancer, characterized by silent progression at early stages, heterogeneous behavior and resistance to chemotherapy and radiotherapy. The clinical challenges posed by RCC require the development of a novel class of biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Couto-Cunha, Anabela, Jerónimo, Carmen, Henrique, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818240/
https://www.ncbi.nlm.nih.gov/pubmed/36612281
http://dx.doi.org/10.3390/cancers15010287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818240/
https://www.ncbi.nlm.nih.gov/pubmed/36612281
http://dx.doi.org/10.3390/cancers15010287

Ejemplares similares